Aktsiaselts PAIRA
Aktsiaselts PAIRA is a AS based in Tallinn, registry code 10461587, status: active. Main activity: Wholesale of medicines and other pharmacy goods. According to EMTA, turnover for Q3 2026 was €2 104 689 with 35 employees.
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Turnover · Q3 2026 2.1 mn €above 92% of companiesindustry median 60 065 € · companies in the industry: 6 941
- Labour taxes per employee 2 999 €above 65% of companiesindustry median 2 104 € · companies in the industry: 4 194
- Revenue · 2025 6.2 mn €above 98% of companiesindustry median 63 691 € · companies in the industry: 10 038
- Net profit margin · 2025 5.7 %above 62% of companiesindustry median 2.7 % · companies in the industry: 7 414
Taxes and turnover
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | 2 104 689 | 153 302 | 104 981 | 35 |
| Q2 2026 | 2 184 897 | 180 899 | 100 245 | 35 |
| Q1 2026 | 2 248 692 | 244 199 | 101 573 | 35 |
| Q4 2025 | 2 114 471 | 279 104 | 120 577 | 35 |
| Q3 2025 | 1 839 246 | 224 684 | 116 214 | 41 |
| Q2 2025 | 1 876 455 | 195 573 | 119 218 | 43 |
| Q1 2025 | 1 752 535 | 245 929 | 117 471 | 42 |
| Q4 2024 | 1 816 953 | 251 217 | 109 092 | 41 |
| Q3 2024 | 1 402 458 | 200 743 | 107 183 | 40 |
| Q2 2024 | 1 571 524 | 191 246 | 105 133 | 40 |
| Q1 2024 | 1 813 100 | 201 715 | 103 780 | 39 |
| Q4 2023 | 1 735 043 | 254 080 | 105 234 | 39 |
| Q3 2023 | 1 412 246 | 226 467 | 111 370 | 39 |
| Q2 2023 | 1 606 927 | 238 473 | 110 879 | 40 |
| Q1 2023 | 1 743 975 | 236 854 | 105 451 | 38 |
| Q4 2022 | 1 691 606 | 216 682 | 92 788 | 38 |
| Q3 2022 | 1 421 344 | 210 908 | 96 829 | 39 |
| Q2 2022 | 1 627 750 | 251 892 | 96 326 | 44 |
| Q1 2022 | 1 629 315 | 169 264 | 96 750 | 43 |
Q3 2026 · calculated from EMTA data
Financials by year
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2025 | 6 247 410 | 354 812 | 1 098 993 | 4 151 592 | 2 659 239 | 33 |
| 2024 | 5 423 568 | 260 041 | 1 026 462 | 3 920 695 | 2 463 427 | 37 |
| 2023 | 5 415 553 | 287 318 | 1 018 278 | 4 054 193 | 2 435 644 | 37 |
| 2022 | 5 344 330 | 330 435 | 925 682 | 3 847 243 | 2 395 926 | 38 |
| 2021 | 5 359 034 | 496 565 | 813 125 | 3 680 422 | 2 296 560 | 35 |
| 2020 | 5 128 636 | 459 700 | 736 223 | 3 351 140 | 2 041 966 | 35 |
| 2019 | 4 677 418 | 348 572 | 702 006 | 3 288 762 | 1 820 666 | 36 |
| 2018 | — | — | — | — | — | 34 |
| 2017 | — | — | — | — | — | 0 |
| 2016 | — | — | — | — | — | 37 |
| 2015 | — | — | — | — | — | 35 |
| 2014 | — | — | — | — | — | 35 |
| 2013 | — | — | — | — | — | 32 |
| 2012 | — | — | — | — | — | 0 |
| 2011 | — | — | — | — | — | 35 |
| 2008 | — | — | — | — | — | 30 |
| 2007 | — | — | — | — | — | 25 |
| 2004 | — | — | — | — | — | 15 |
| 2003 | — | — | — | — | — | 13 |
| 2002 | — | — | — | — | — | 7 |
| 2001 | — | — | — | — | — | 5 |
| 2000 | — | — | — | — | — | 3 |
| 1999 | — | — | — | — | — | 5 |
| 1998 | — | — | — | — | — | 1 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2025
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2025 | 1 Jan 2025 – 31 Dec 2025 | 17 Jun 2026 | Company’s own · audited | e-Äriregister |
| 2024 | 1 Jan 2024 – 31 Dec 2024 | 25 Jun 2025 | Company’s own · audited | e-Äriregister |
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 19 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 16 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 27 Jun 2022 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 16 Jun 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 26 Jun 2020 | Company’s own · audited | e-Äriregister |
Commercial pledges
| No. | Amount | Pledgee | Period |
|---|---|---|---|
| 3 | 197 995 € | Swedbank AS | 15 Jul 2014 – in force |
| 2 | 70 207 € | Swedbank AS | 4 Jun 2013 – in force |
| 1 | 1 405 000 EEK | aktsiaselts Hansapank | 2 May 2002 – in force |
Board
- Nasdaq CSD SEKeeper of the share ledger · since 27 Sep 2017
- Oleg PolozkovBoard member · since 24 Apr 2009
- Vladimir NovitškovBoard member · since 14 May 2015
- Boriss KušnarjovBoard member · since 24 Sep 2021
Right of representation
Any member of the management board may represent the public limited company in all transactions.
Owners
No owner information.
Owner in
- 100%
Beneficial owners
- Oleg PolozkovDirect ownership · since 7 Sep 2018
- Vladimir NovitškovDirect ownership · since 7 Sep 2018
- Boriss KušnarjovDirect ownership · since 5 Sep 2018
Founders and other persons
- Irina SomovaAudit firm · 19 May 2011
- Karina UrvikChairman of the supervisory board · 13 Sep 2021
- Jevgeni NovitškovSupervisory board member · 13 Sep 2021
- Vladimir TšebakovSupervisory board member · 13 Sep 2021
- Omanikukonto: BORISS KUŠNARJOVShareholder · 8 563 € · 16 Aug 2023
- Omanikukonto: OLEG POLOZKOVShareholder · 8 499 € · 16 Aug 2023
- Omanikukonto: VLADIMIR NOVITŠKOVShareholder · 8 499 € · 16 Aug 2023
Related companies
Activities (EMTAK)
- 46461Wholesale of medicines and other pharmacy goods Main
- 68201Rental and operating of own or leased real estate
- 73301Public relations and communication activities
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10019917 / M4 19 Mar 2026 |
Ruling to correct data outside an entry | 2 Apr 2026 | Deficiencies eliminated 24 Mar 2026 |
|
| Ä 10019917 / 17 2 Oct 2024 |
Amendment entry | In force 2 Oct 2024 |
||
| Ä 10019917 / 16 2 Oct 2024 |
Entry refused: deficiencies not eliminated | In force 1 Nov 2024 |
||
| Ä 10019917 / M3 31 Jul 2024 |
Ruling to eliminate deficiencies | 14 Sep 2024 | In force 22 Aug 2024 |
|
| Ä 10019917 / 15 24 Sep 2021 |
Amendment entry | In force 24 Sep 2021 |
||
| Ä 10019917 / 14 16 Jan 2018 |
Amendment entry | In force 16 Jan 2018 |
||
| Ä 10019917 / 13 7 Nov 2017 |
Amendment entry | In force 7 Nov 2017 |
||
| Ä 10019917 / 12 27 Sep 2017 |
Amendment entry | In force 27 Sep 2017 |
||
| Ä 10019917 / 11 14 Sep 2016 |
Amendment entry | In force 14 Sep 2016 |
||
| Ä 10019917 / 10 14 May 2015 |
Amendment entry | In force 14 May 2015 |
||
| Ä 10019917 / M2 12 May 2015 |
Ruling to eliminate deficiencies | 27 May 2015 | Deficiencies eliminated 14 May 2015 |
|
| K 10019917 / 9 15 Jul 2014 |
Commercial pledge entered | In force 15 Jul 2014 |
||
| K 10019917 / 8 4 Jun 2013 |
Commercial pledge entered | In force 4 Jun 2013 |
||
| Ä 10019917 / 7 9 Dec 2011 |
Amendment entry | In force 9 Dec 2011 |
||
| Ä 19917 / 6 24 Apr 2009 |
Amendment entry | In force 24 Apr 2009 |
||
| Ä 19917 / 5 3 Dec 2008 |
Deletion of activities from the registry card | In force 3 Dec 2008 |
||
| K 65114 / 3 14 Apr 2005 |
Commercial pledge amended | In force | ||
| K 65114 / 2 18 Oct 2003 |
Commercial pledge amended | In force | ||
| Ä 19917 / 4 17 Sep 2003 |
Amendment entry | In force | ||
| Ä 19917 / 3 29 Aug 2003 |
Entry decision on the register’s own initiative | In force | ||
| K 65114 2 May 2002 |
Commercial pledge entered | In force |
Sources: e-Äriregister and EMTA. Data updated 31 Oct 2026. Open at the source ↗ · Report an error in the data